Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Benghiat

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 7, 2014
Can protons or altered fractionation decrease neurotoxicity after chemoradiation in head and neck cancer?H Benghiat, J Cashmore, T Williams, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 6, 2016
Does Dose to an Oral Mucosa Organ at Risk Predict the Duration of Grade 3 Mucositis after Intensity-modulated Radiotherapy for Oropharyngeal Cancer?S Yahya, H Benghiat, P Nightingale, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 3, 2016
WITHDRAWN: Does Dose to an Oral Mucosa Organ at Risk Predict the Duration of Grade 3 Mucositis after Intensity-modulated Radiotherapy for Oropharyngeal Cancer?S Yahya, H Benghiat, P Nightingale, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 25, 2017
Hypofractionated Accelerated Chemoradiation for Oropharyngeal Cancer and the 2016 Royal College of Radiologists' Fractionation GuidelinesC Fong, I S Boon, C S Boon, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 22, 2009
Effect of the UK postcode lottery on survival of patients with metastatic renal cancer: an audit of outcomes in patients with metastatic renal cancer suitable for treatment with tyrosine kinase inhibitorsN James, J Pascoe, A Zachariah, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 3, 2025
Hypo-Fractionated Radiotherapy to the Cavity for Resected Brain Metastases: A UK SeriesC L Barker, T Shane, C Hodgson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 10, 2024
Clinical Outcomes and Relevance of Composite V12 Gy in Patients With Four or More Brain Metastases Treated With Single Fraction Stereotactic RadiosurgeryS Parikh, U Alluri, G Heyes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 3, 2018
Dexamethasone-related adrenal insufficiency in patients with brain and skull base tumoursH Benghiat, P Sanghera, D Stange, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 3, 2018
Evaluation of Response to Stereotactic Radiosurgery in Brain Metastases Using Multiparametric Magnetic Resonance Imaging and a Review of the LiteratureV Sawlani, N Davies, M Patel, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 5, 2024
Outcomes of Patients With Five or More Brain Metastases Treated With Stereotactic Radiosurgery From 2014 to 2019: A UK SeriesH Benghiat, J Hodson, M Hickman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 7, 2014
Can protons or altered fractionation decrease neurotoxicity after chemoradiation in head and neck cancer?H Benghiat, J Cashmore, T Williams, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 6, 2016
Does Dose to an Oral Mucosa Organ at Risk Predict the Duration of Grade 3 Mucositis after Intensity-modulated Radiotherapy for Oropharyngeal Cancer?S Yahya, H Benghiat, P Nightingale, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 3, 2016
WITHDRAWN: Does Dose to an Oral Mucosa Organ at Risk Predict the Duration of Grade 3 Mucositis after Intensity-modulated Radiotherapy for Oropharyngeal Cancer?S Yahya, H Benghiat, P Nightingale, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 25, 2017
Hypofractionated Accelerated Chemoradiation for Oropharyngeal Cancer and the 2016 Royal College of Radiologists' Fractionation GuidelinesC Fong, I S Boon, C S Boon, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 22, 2009
Effect of the UK postcode lottery on survival of patients with metastatic renal cancer: an audit of outcomes in patients with metastatic renal cancer suitable for treatment with tyrosine kinase inhibitorsN James, J Pascoe, A Zachariah, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 3, 2025
Hypo-Fractionated Radiotherapy to the Cavity for Resected Brain Metastases: A UK SeriesC L Barker, T Shane, C Hodgson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 10, 2024
Clinical Outcomes and Relevance of Composite V12 Gy in Patients With Four or More Brain Metastases Treated With Single Fraction Stereotactic RadiosurgeryS Parikh, U Alluri, G Heyes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 3, 2018
Dexamethasone-related adrenal insufficiency in patients with brain and skull base tumoursH Benghiat, P Sanghera, D Stange, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 3, 2018
Evaluation of Response to Stereotactic Radiosurgery in Brain Metastases Using Multiparametric Magnetic Resonance Imaging and a Review of the LiteratureV Sawlani, N Davies, M Patel, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 5, 2024
Outcomes of Patients With Five or More Brain Metastases Treated With Stereotactic Radiosurgery From 2014 to 2019: A UK SeriesH Benghiat, J Hodson, M Hickman, et al.
Pageof 1